| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.003 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.31 | 0.003 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |